Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas

Gliomas are the most common malignant brain tumors, which are often associated with high-grade tumors characterized by an inferior prognosis and low patient survival rates in both children and adults. Surgical removal and tumor resection are the primary treatment approaches for gliomas. In such cases, whole-brain radiation therapy is also employed as a therapeutic option, which itself has significant side effects, and studies have shown limited impact on improving patient survival. Targeted therapy and recently investigated approaches such as targeted therapy have shown some tumor regression,

Trial Details

NCT ID
NCT06687681
Phase
PHASE2
Sponsor
Marzieh Ebrahimi
Status
RECRUITING
Cancer Type
Glioblastoma (GBM) Brain Cancer
Locations (sample)
  • Tehran, Iran|35.69439,51.42151

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Glioblastoma (GBM) Brain Cancer Trials on Trialify →